Tourmaline Bio Inc. (TRML) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tourmaline Bio Inc.

    NASDAQ: TRML · Real-Time Price · USD
    26.74
    1.64 (6.53%)
    At close: Sep 05, 2025, 3:59 PM
    27.28
    2.02%
    After-hours: Sep 05, 2025, 07:23 PM EDT

    Tourmaline Bio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 39K 33K 6K 623K
    Gross Profit
    		 -39K -33K -6K -623K
    Operating Income
    		 -89.73M -45.41M -19.7M -47.51M
    Interest Income
    		 16.52M 3.29M n/a n/a
    Pretax Income
    		 -73.21M -42.12M -19.7M -47.83M
    Net Income
    		 -73.21M -42.12M -19.7M -904
    Selling & General & Admin
    		 22.75M 13.04M 2.17M 692.00
    Research & Development
    		 66.98M 32.37M 17.53M 212.00
    Other Expenses
    		 n/a n/a n/a 46.88M
    Operating Expenses
    		 89.73M 45.41M 19.7M 46.88M
    Interest Expense
    		 n/a n/a n/a 326K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 89.73M 45.41M 19.7M 47.51M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 25.35M 4.75M 20.34M 10.88M
    Shares Outstanding (Diluted)
    		 25.35M 4.75M 20.34M 10.88M
    EPS (Basic)
    		 -2.89 -8.87 -0.97 -0.00
    EPS (Diluted)
    		 -2.89 -8.87 -0.97 -0.00
    EBITDA
    		 -89.73M -45.38M -19.7M -46.88M
    EBIT
    		 -73.21M -42.12M -19.7M -47.51M
    Depreciation & Amortization
    		 -16.52M 33K 6K 623K

    Add to Watchlist